Renal function in rheumatiod arthritis patients treated with methotrexate and infliximab

Clinical and Experimental Rheumatology

Volumn 22, Issue 4, 2004, Pages 469-472

  Wiland, Piotr ^a,c   Wiela Hojenska, Anna ^b   GlowsKa, Agnieszka ^a   Chlebicki, Arkadiusz ^a   Hurkacz, Magdalena ^b   Orzechowska Juzwenko, Krystyna ^b   Szechinski, Jacek ^b  

^a Regional Railway Hospital of Wroclaw   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Okregowy Szpital Kolejowy   (Poland)

Author keywords

Amyloidosis; Infliximab; Methotrexate; N acetyl D glucos aminidase; Renal function; Rheumatoid arthritis

Indexed keywords

AMYLOID; CREATININE; INFLIXIMAB; METHOTREXATE; N ACETYL BETA GLUCOSAMINIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; ACETYLGLUCOSAMINIDASE; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY;

ABDOMEN; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG INFUSION; DRUG MONITORING; ENZYME ACTIVITY; ENZYMURIA; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; NEPHROTOXICITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; URINALYSIS; ADOLESCENT; DRUG COMBINATION; DRUG EFFECT; ENZYMOLOGY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY PROXIMAL TUBULE; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY TUBULES, PROXIMAL; METHOTREXATE; MIDDLE AGED;

EID: 4143137553     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. SINGH R, CUCHACOVICH R, HUANG W, ESPINOZA LR: Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 2002; 29: 636-7.
2. YEE AM, POCHAPIN MB: Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001; 135: 27-31.
3. DIENER U, KNOLL E, LANGER B, RAUTENSTRAUCH H, RATGE D, WISSER H: Urinary excretion of NAG and alaninoaminopeptodase in patients receiving amikacin or cisplatinum. Clin Chim Acta 1981; 112: 149-57.
4. WIELA-HOJEŃSKA A, ORZECHOWSKA-JUZWENKO K: N-acetyl-β-D-glucosaminidase and its clinical significance (in Polish). Pol Arch Med Wewn 1999; 101: 359-66.
5. CHATTERJEE S, VELICER LL, SWEELEY CC: Glycosphingolipid glycosyl hydrolases and glycosidases of synchronized human KB cells. J Biol Chem 1975; 250: 4972-9.
6. ZWIERZ K, GINDZIENSKI A, GLOWACKA D, POROWSKI T: The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung 1981; 38: 145-52.
7. LIPSKY PE, DESIREE MFM, VAN DER HEIJDE DM et al.: Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594-602
8. DUCLOUX D, BRESSON-VAUTRIN C, CHALOPIN J: Use of pentoxifylline in membranous nephropathy. Lancet 2001; 357: 1672-3.
9. DREWE E, MCDERMOTT EM, POWELL RJ: Treatment of the nephrotic syndrome with etanercept in a patient with the tumour necrosis factor receptor-associated periodic syndrome (letter). N Engl J Med 2000; 343: 1044-5.
10. BOOTH AD, JEFFERSON HJ, AYLIFFE W, ANDREWS PA, JAYNE DR: Safety and efficacy of TNF blockade in relapsing vasculitis. Ann Rheum Dis 2002; 61: 559 (letter).
11. BENDELE A, SEELY J, RICHEY C, SENNELLO G, SHOPP G: Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins. Toxicol Sci 1998; 42: 152-7.
12. NIEMIR ZI: What is the trigger of renal cytokine production in glomerular diseases? Adv Clin Exp Med 1998; 7: 55-6.
13. SURANYI MG, GUASCH A, HALL BM, MYERS BD: Elevated levels of tumor necrosis factor-alpha in the nephrotoc syndrome in humans. Am J Kidney Dis 1993; 21: 251-9.
14. KACPRZYK F, CHRZANOWSKI W: Tumour necrosis factor (TNF) and interleukin-6 (IL-6) in glomerulonephritis (in Polish). Pol Arch Med Wewn 1996; 96: 224-33.
15. VERSCHUEREN P, LENSEN F, LERUT E, CLAES K, DE VOS R, VAN DAMME B, WESTHOVENS R: Benefit of anti-TNF-α treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis. Ann Rheum Dis 2003; 62: 368-9.
16. WILAND P, WIELA-HOJENSKA A, SWIERKOT J, HURKACZ M, ORZECHOWSKA-JUZWENKO K, SZECHINSKI J: Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose methotrxate (in Polish). Pol Arch Med Wewn 2003; 110: 855-62.
17. GORMLEY SM, MCBRIDE WT, ARMSTRONG MA et al.: Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology 2000; 93:1210-6.
18. WILAND P, ŚWIERKOT J, SZECHIŃSKI J: N-acetyl-β-D-glucosaminidase urinary excretion as an early indicator of kidney dysfunction in rheumatoid arthritis patients on low-dose methotrexate treatment. Br J Rheumatol 1997; 36: 59-63.
19. TSYBUL'KOV SV, BARANOV AA, BORODIN AG, KORSHUNOV NI, KIRDIANOV Slu: Tumor necrosis factor-alpha and kidney damage in rheumatoid arthritis. Ter Arkh 2001; 73: 8-11.
20. ELKAYAM O, HAWKINS PN, LACHMANN H, YARON M, CAPSI D: Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum 2002; 46: 2571-3.